← All stocks

Emergent BioSolutions Inc.

EBS Net selling
CIK 0001367644 #3771 in the set updated 20 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.42M
$577.20K on a plan · $263.08K straight out of an exercise
Sold at will
$579.22K
3 of 14 sales
Net
−$1.42M
−$579.22K against sales at will

By person

17 insiders · 14 transactions
3.9×

Joseph Papa holds only 3.9 times base salary in stock. $4.14M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Papa last reported holding, valued at $8.40, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
DeGolyer Donald W
Director
$317.62K (3)
−$317.62K
129,721
0.2530%
$1.09M
−4.7%
Glessner Coleen
EVP, Quality & Ethics, and CPL
$306.08K (1)
−$306.08K
202,201
0.3944%
$1.70M
+23.9%
Richard Ronald
Director
$263.08K (2) scheduled
−$263.08K
123,761
0.2414%
$1.04M
+74.0%
Dayal Sujata Tyagi
Director
$201.13K (3) scheduled
−$201.13K
100,563
0.1961%
$844.73K
+59.3%
Zoon Kathryn C
Director
$144.45K (2) scheduled
−$144.45K
79,941
0.1559%
$671.50K
+46.7%
Katkin Keith
Director
$128.18K (1) scheduled
−$128.18K
96,294
0.1878%
$808.87K
+60.8%
Williams Paul Anthony
SVP, Products Business
$58.96K (2) scheduled
−$58.96K
159,098
0.3103%
$1.34M
+553.8%
PAPA JOSEPH C
President and CEO
493,153
0.9618%
$4.14M
LINDAHL RICHARD S
EVP, Chief Financial Officer
374,083
0.7296%
$3.14M
+139.8%
Hartzel William
SVP, Bioservices
185,558
0.3619%
$1.56M
+285.7%
Lowry Simon C
SVP, R&D, CMO
177,914
0.3470%
$1.49M
Perl Jessica
SVP, General Counsel, Corp Sec
165,286
0.3224%
$1.39M
+2,329%
Fowler Neal Franklin
Director
160,847
0.3137%
$1.35M
+18.2%
Harsanyi Zsolt
Chairman
149,076
0.2907%
$1.25M
+66.9%
SULLIVAN LOUIS W
Director
139,098
0.2713%
$1.17M
+32.9%
White Marvin L
Director
113,839
0.2220%
$956.25K
+66.5%
FOWLER JOHN D JR
Director
30,350
0.0592%
$254.94K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 2
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 1,348,892
History held since 10 Nov 2016